Amussen Hunsaker Associates LLC Pa Vmed Inc. Transaction History

Amussen Hunsaker Associates LLC

  • $645 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$2.46 - $8.74 $49,815 - $176,985
-20,250 Closed
0 $0
Q2 2021

Aug 17, 2021
BUY
$3.95 - $6.88 $79,987 - $139,320
20,250 New
20,250 $129,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0
View Full List

About PAVmed Inc.

PAVM Quotes by TradingView
  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $93.7M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track This Portfolio

Track Amussen Hunsaker Associates LLC Portfolio

Follow Amussen Hunsaker Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amussen Hunsaker Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Amussen Hunsaker Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email